Fecal Microbiota Transplantation as an Immunomodulatory and Anti-Infective Agent

Microbiota 2022 Congress speaker Jarosław BilinskDr. Jarosław Biliński, from Medical University of Warsaw, Poland will join the Targeting Microbiota 2022 Congress and give a presentation entitled "Fecal Microbiota Transplantation as an Immunomodulatory and Anti-Infective Agent".

There is mounting evidence that the gut microbiome directly influences immune responses, especially in patients with hematological malignancies undergoing hematopoietic cell transplantation. Recent studies show that fecal microbiota transplantation could decrease the number of infectious complications, decolonize the gut from antibiotic-resistant bacteria and even treat immune complications like graft-versus-host disease. More attention is paid to the prophylactic use of microbiota modulation in most affected patients, which could revolutionize current practices.

Join Dr. Biliński in Targeting Microbiota 2022 to benefit from his experience and better understand microbiota immunotherapy.

Targeting Microbiota 2022 Congress
October 19-21, 2022 - Paris, France
www.microbiota-site.com

Microbiota in the Press & Media

  • 1
  • 2
  • 3
Prev Next